Is there a wait time for vaccines after stopping Cosentyx?
No mandatory wait time exists for most vaccines after discontinuing Cosentyx (secukinumab), a biologic that suppresses IL-17 for psoriasis, psoriatic arthritis, and ankylosing spondylitis. Guidelines prioritize live vaccines due to infection risk during immunosuppression.[1]
Live vaccines: Key restrictions
Avoid live vaccines (e.g., MMR, varicella, oral polio, yellow fever) while on Cosentyx and for up to 4-6 weeks after the last dose, as immunosuppression may persist. The prescribing information states: "Live vaccines should not be given concurrently with Cosentyx."[1] Post-treatment, consult a doctor; risk drops as drug clears (half-life ~25-30 days).[2]
Inactivated vaccines: Safe anytime?
Inactivated or subunit vaccines (e.g., flu shot, COVID-19 mRNA vaccines, Tdap, pneumococcal) can be given during or after Cosentyx without delay. Studies show adequate immune response, though slightly reduced compared to non-immunosuppressed patients.[3][4]
| Vaccine Type | During Cosentyx | After Stopping |
|--------------|-----------------|---------------|
| Live (e.g., shingles Zostavax, nasal flu) | Avoid | Wait 4-6 weeks minimum; confirm with bloodwork |
| Inactivated (e.g., Shingrix, Prevnar) | Recommended | No wait needed |
What if I need a vaccine urgently?
Timing depends on infection risk vs. immunosuppression level. Rheumatology guidelines (e.g., ACR) recommend checking antibody titers or CD4 counts for live vaccines post-biologic. Cosentyx doesn't require washout like TNF inhibitors for some surgeries or transplants.[5]
Impact on vaccine effectiveness
Cosentyx reduces antibody responses to some vaccines by 10-20% (e.g., pneumococcal), but boosters help. COVID-19 vaccine studies confirm seroconversion in most patients on IL-17 inhibitors.[4][6]
Doctor's role and patient experiences
Always check with your rheumatologist or dermatologist—they assess based on dose timing, disease activity, and vaccine type. Patient forums report no issues with inactivated shots immediately post-Cosentyx, but live vaccine delays for safety.[7]
Sources
[1] Cosentyx Prescribing Information (Novartis)
[2] FDA Label, Pharmacokinetics Section
[3] ACR Guidelines on Vaccinations in Rheumatic Diseases (2021)
[4] Study on IL-17 Inhibitors and Vaccine Response (JAMA Dermatol, 2022)
[5] EULAR Recommendations for Vaccinations (Ann Rheum Dis, 2019)
[6] COVID-19 Vaccine Efficacy in Psoriasis Patients on Biologics (Lancet Rheumatol, 2022)
[7] Patient Discussions on Drugs.com and Reddit (r/PsoriaticArthritis)